MAP
CRL icon

Moody Aldrich Partners’s Charles River Laboratories CRL Stock Holding History

Moody Aldrich Partners’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-526
Closed -$217K – 164
2021
Q3 		$217K Buy
+526
New +$218K 0.03% 163

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Moody Aldrich Partners's CRL Position: Q4 2021 in Review

Moody Aldrich Partners sold out of Charles River Laboratories (CRL) in Q4 2021, closing a stake of 526 shares — an estimated $217K sold.

Moody Aldrich Partners first reported a position in CRL in Q3 2021 and held it in 1 quarter. The position peaked at $217K in Q3 2021. 707 funds tracked by Wall St. Rank hold CRL as of Q4 2021.

  • Moody Aldrich Partners reported no remaining Charles River Laboratories position as of Q4 2021 after selling out during the quarter.
  • Moody Aldrich Partners sold 526 Charles River Laboratories shares in Q4 2021, an estimated $217K.
  • Moody Aldrich Partners first reported a position in Charles River Laboratories in Q3 2021 and held it in 1 quarter.
  • Moody Aldrich Partners's Charles River Laboratories position peaked at $217K in Q3 2021.
  • 707 funds tracked by Wall St. Rank held Charles River Laboratories as of Q4 2021.

Based on Moody Aldrich Partners's 13F filing for Q4 2021, filed 2 Feb 2022.